Developmental Teratogeny Test
Call Us Now:
Talk To Us:
Developmental teratogeny testing identifies substances that disrupt embryonic development, potentially causing congenital abnormalities. Essential for evaluating the teratogenic risks of chemicals and pollutants, these tests provide insights into their developmental impact on aquatic species. At BioVenic, specialized services are offered to support thorough environmental risk assessments, ensuring adherence to regulatory standards while safeguarding aquatic ecosystems and public health.
Developmental teratogeny testing utilizes embryos from aquatic species, including zebrafish, to evaluate the potential of chemicals to disrupt normal development. This approach provides a cost-effective and ethical alternative to traditional mammalian models, offering efficiency in identifying teratogenic risks. Widely used in chemical safety evaluation, environmental monitoring, and regulatory compliance, it aligns with the 3Rs principles by significantly reducing animal usage while delivering high-quality, reliable data. Recent advancements in automation and standardized protocols have further expanded its applications, making it a crucial tool in developmental toxicology and environmental safety assessments.
Fig. 1 The characteristic phenotypes associated with zebrafish developmental toxicity and teratogenicity. (He, J. H., et al., 2014)
Developmental teratogeny testing provides critical insights into the effects of various substances on embryonic development, ensuring safety and advancing research.
BioVenic has extensive experience in conducting Developmental Teratogenicity Tests (DTT) on aquatic animals. Comprehensive DTT services are available through our company, utilizing various fish species like zebrafish to evaluate the potential teratogenic effects of chemicals on the early stages of development. By identifying compounds that may cause developmental abnormalities, our testing protocols ensure better safety assessments in environmental and pharmaceutical research.

Embryo Incubation
Incubate zebrafish embryos with five different concentrations of the test substance, spaced by a constant factor of 2, from 0 to 96 hours post-fertilization (hpf).

Automated Imaging
After incubation, embryos undergo automated imaging for the assessment of teratogenicity.

Development Monitoring
The embryos are closely observed for developmental changes, noting any major morphological alterations or toxic effects. Important observations include the transition from egg to embryo and early signs of coagulation in affected samples.

Phenotype Evaluation
Evaluate the teratogenic effects using a validated panel of phenotypic markers to identify morphological abnormalities and toxic effects.
Teratogenicity & Mortality Assessment
Monitor and record the relationship between mortality rates and teratogenicity to assess the severity of developmental defects.

Teratogenic Index Calculation
Calculate the teratogenic potency (teratogenic index) based on the observed mortality and teratogenic effects across different concentrations.

Professional Team

Customized Services

Innovative Technology

Efficient Services
At BioVenic, expert developmental teratogenicity testing services are offered to evaluate the impact of chemicals on the development of aquatic species. These reliable and cost-effective solutions ensure scientifically advanced and ethical assessments. For accurate and timely results that support your research needs, please contact us.
Reference
Our products and services are for research use only and cannot be used for any clinical purposes.